CytomX Therapeutics
CTMX
CTMX
110 hedge funds and large institutions have $236M invested in CytomX Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less call options, than puts
Call options by funds: $238K | Put options by funds: $287K
39% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 44
Holders
110
Holding in Top 10
–
Calls
$238K
Puts
$287K
Top Buyers
| 1 | +$25.1M | |
| 2 | +$20M | |
| 3 | +$10.4M | |
| 4 |
O
OrbiMed
New York
|
+$6.03M |
| 5 |
Millennium Management
New York
|
+$1.43M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$16.6M | |
| 3 | -$7.63M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.69M |
| 5 |
State Street
Boston,
Massachusetts
|
-$5.62M |